结节状小叶间隔增厚可见于癌性淋巴管炎、结节病和硅肺。
Nodular thickening of interlobular septa can be seen in lymphangitic carcinomatosis, sarcoidosis, and silicosis.
然而，在结节病和煤尘肺，间隔增厚常较淋巴管转移癌轻。
However, in sarcoidosis and coal worker's pneumoconiosis, septal thickening is usually less extensive than that seen in patients with lymphatic spread of tumor.
根管治疗是现今牙髓病和根尖周病的基本治疗方法。
Root canal therapy is a fundamental method of treating pulpal and periapical diseases nowadays.
这里显示这种肠病缺乏腺管、有丝分裂活跃、刷状缘消失，伴有淋巴细胞和浆细胞浸润（B细胞对麦胶敏感）。
The enteropathy shown here has loss of crypts, increased mitotic activity, loss of brush border, and infiltration with lymphocytes and plasma cells (B-cells sensitized to gliaden).
临床上病兔多尿与脱水可能主要与肾远曲小管和集合管的上皮细胞凋亡有关。
The polyuria and dehydration of ill rabbits in clinic were related to renal epithelium apoptosis of distal convoluted renal tubule and collecting duct.
方法对近5年来收治的25例大骨节病致踝管综合征患者的诊断和治疗进行分析。
Methods 25 cases with tarsal tunnel syndrome caused by KBD in recent 5 years were involved in this study.
结论：自制透明模拟根管模型可以满足牙体牙髓病学前期实习根管治疗教学的要求，提高学生学习兴趣和操作技能，增强根管治疗教学效果。
CONCLUSION: Transparent simulated root canals blocks could satisfy the demand of pre-clinical practice training of root canal treatment and enhance the learning effect.
对比和评价在一次、或者两次及更多次看牙医过程中完成根管治疗，是否使用药物，对治疗效果以及病发症产生怎样影响。
To determine whether completion of root canal treatment (RoCT) in a single visit or over two or more visits, with or without medication, makes any difference in term of effectiveness or complications.
根管治疗是目前牙髓病和根尖周病最有效的治疗方法。
Root canal therapy is currently the most effective treatment for pulpal and periapical diseases.
卫生局人员称，病人已被诊断患有管园线虫病，这是一种由寄生虫引起的疾病，寄生虫会影响大脑和脊髓，并可导致脑膜炎。
Patients were diagnosed with a type of angiostrongyliasis, a disease caused by parasites that affects the brain and spinal cord, and can lead to meningitis, the bureau said.
此外，美国FDA指出，由于内毒素规格变化的实施，结核病抗原和零管的制造是不具备过程验证和释放的情况下进行的。
Furthermore since the endotoxin specification change was implemented, the TB Antigen and Nil tubes were manufactured without process validation and released, "FDA said."
此外，美国FDA指出，由于内毒素规格变化的实施，结核病抗原和零管的制造是不具备过程验证和释放的情况下进行的。
Furthermore since the endotoxin specification change was implemented, the TB Antigen and Nil tubes were manufactured without process validation and released, "FDA said."
应用推荐